137 related articles for article (PubMed ID: 16093975)
1. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer.
Montie JE
J Urol; 2005 Sep; 174(3):869-70. PubMed ID: 16093975
[No Abstract] [Full Text] [Related]
2. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer.
Guo Z; Linn JF; Wu G; Anzick SL; Eisenberger CF; Halachmi S; Cohen Y; Fomenkov A; Hoque MO; Okami K; Steiner G; Engles JM; Osada M; Moon C; Ratovitski E; Trent JM; Meltzer PS; Westra WH; Kiemeney LA; Schoenberg MP; Sidransky D; Trink B
Nat Med; 2004 Apr; 10(4):374-81. PubMed ID: 15034568
[TBL] [Abstract][Full Text] [Related]
3. CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas.
Ratliff TL
J Urol; 2005 Nov; 174(5):2066. PubMed ID: 16217398
[No Abstract] [Full Text] [Related]
4. [Urothelial cancers. Cytogenetic and molecular biology principles].
Strohmeyer T
Urologe A; 1994 Mar; 33(2):122-7. PubMed ID: 7909968
[TBL] [Abstract][Full Text] [Related]
5. Gene expression in superficial bladder cancer in a tumor-model-system (RBT).
Knopf HJ; von Moorselaar RJ; Debruyne FM; Schalken JA
Investig Urol (Berl); 1994; 5():76-9. PubMed ID: 7719325
[No Abstract] [Full Text] [Related]
6. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
Ahmed HU; Arya M; Patel HR
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1011-22. PubMed ID: 16336092
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of urinary bladder malignancy.
Karr JP; Pontes JE; Murphy GP; Gibas Z; Sandberg AA
Prog Clin Biol Res; 1984; 162A():331-46. PubMed ID: 6592614
[No Abstract] [Full Text] [Related]
8. Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.
Wu G; Guo Z; Chatterjee A; Huang X; Rubin E; Wu F; Mambo E; Chang X; Osada M; Sook Kim M; Moon C; Califano JA; Ratovitski EA; Gollin SM; Sukumar S; Sidransky D; Trink B
Cancer Res; 2006 Oct; 66(20):9829-36. PubMed ID: 17047043
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
[TBL] [Abstract][Full Text] [Related]
10. Bladder cancer: modeling and translation.
Rosenberg JE; Hahn WC
Genes Dev; 2009 Mar; 23(6):655-9. PubMed ID: 19299556
[TBL] [Abstract][Full Text] [Related]
11. [Human oncogenes].
Barbacid M
Rev Clin Esp; 1986 Nov; 179(8):412-27. PubMed ID: 3550930
[No Abstract] [Full Text] [Related]
12. p63 gene expression study and early bladder carcinogenesis.
Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
[TBL] [Abstract][Full Text] [Related]
13. CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas.
Schultz IJ; Kiemeney LA; Witjes JA; Schalken JA; Willems JL; Swinkels DW; de Kok JB
Int J Cancer; 2005 Aug; 116(2):282-4. PubMed ID: 15800923
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of human bladder cancer.
Olumi AF; Skinner EC; Tsai YC; Jones PA
Semin Urol; 1990 Nov; 8(4):270-7. PubMed ID: 1980959
[No Abstract] [Full Text] [Related]
15. Oncogene activation during multi-stage carcinogenesis.
Bowden GT
Prog Clin Biol Res; 1990; 340D():1-12. PubMed ID: 2164691
[No Abstract] [Full Text] [Related]
16. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.
Elsamman E; Fukumori T; Ewis AA; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Takahashi M; Nishitani MA; Baba Y; Kanayama HO
Urol Oncol; 2006; 24(2):109-15. PubMed ID: 16520272
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
[TBL] [Abstract][Full Text] [Related]
18. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
19. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
20. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
